146 related articles for article (PubMed ID: 28267583)
1. Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation.
Clark SD; Kenakin TP; Gertz S; Hassler C; Gay EA; Langston TL; Reinscheid RK; Runyon SP
Neuropharmacology; 2017 May; 118():69-78. PubMed ID: 28267583
[TBL] [Abstract][Full Text] [Related]
2. [tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies.
Ruzza C; Rizzi A; Camarda V; Pulga A; Marzola G; Filaferro M; Novi C; Ruggieri V; Marzola E; Vitale G; Salvadori S; Guerrini R; Calo' G
Peptides; 2012 Apr; 34(2):404-11. PubMed ID: 22342393
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
Leonard SK; Dwyer JM; Sukoff Rizzo SJ; Platt B; Logue SF; Neal SJ; Malberg JE; Beyer CE; Schechter LE; Rosenzweig-Lipson S; Ring RH
Psychopharmacology (Berl); 2008 May; 197(4):601-11. PubMed ID: 18311561
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1.
Camarda V; Ruzza C; Rizzi A; Trapella C; Guerrini R; Reinscheid RK; Calo G
Peptides; 2013 Oct; 48():27-35. PubMed ID: 23911665
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.
Guerrini R; Camarda V; Trapella C; Calò G; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
J Med Chem; 2009 Jan; 52(2):524-9. PubMed ID: 19113861
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide S receptor ligands: a patent review (2005-2016).
Ruzza C; Calò G; Di Maro S; Pacifico S; Trapella C; Salvadori S; Preti D; Guerrini R
Expert Opin Ther Pat; 2017 Mar; 27(3):347-362. PubMed ID: 27788040
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.
Xu YL; Reinscheid RK; Huitron-Resendiz S; Clark SD; Wang Z; Lin SH; Brucher FA; Zeng J; Ly NK; Henriksen SJ; de Lecea L; Civelli O
Neuron; 2004 Aug; 43(4):487-97. PubMed ID: 15312648
[TBL] [Abstract][Full Text] [Related]
8. Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor.
Ruzza C; Pulga A; Rizzi A; Marzola G; Guerrini R; Calo' G
Neuropharmacology; 2012 Apr; 62(5-6):1999-2009. PubMed ID: 22248636
[TBL] [Abstract][Full Text] [Related]
9. Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects.
Lukas M; Neumann ID
Neuropharmacology; 2012 Jan; 62(1):398-405. PubMed ID: 21871467
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
Camarda V; Rizzi A; Ruzza C; Zucchini S; Marzola G; Marzola E; Guerrini R; Salvadori S; Reinscheid RK; Regoli D; Calò G
J Pharmacol Exp Ther; 2009 Feb; 328(2):549-55. PubMed ID: 18971372
[TBL] [Abstract][Full Text] [Related]
11. RTI-263, a biased neuropeptide S receptor agonist that retains an anxiolytic effect, attenuates cocaine-seeking behavior in rats.
Huang Y; Wojciechowski A; Feldman K; Ettaro R; Veros K; Ritter M; Carvalho Costa P; DiStasio J; Peirick JJ; Reissner KJ; Runyon SP; Clark SD
Neuropharmacology; 2023 Dec; 241():109743. PubMed ID: 37820934
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of human neuropeptide S analogues modified in position 2.
Camarda V; Trapella C; Calo G; Guerrini R; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
J Med Chem; 2008 Feb; 51(3):655-8. PubMed ID: 18181564
[TBL] [Abstract][Full Text] [Related]
13. The ventromedial hypothalamic nucleus plays an important role in anxiolytic-like effect of neuropeptide S.
Jiang JH; Peng YL; Zhang PJ; Xue HX; He Z; Liang XY; Chang M
Neuropeptides; 2018 Feb; 67():36-44. PubMed ID: 29195839
[TBL] [Abstract][Full Text] [Related]
14. Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68.
Ruzza C; Rizzi A; Trapella C; Pela' M; Camarda V; Ruggieri V; Filaferro M; Cifani C; Reinscheid RK; Vitale G; Ciccocioppo R; Salvadori S; Guerrini R; Calo' G
Peptides; 2010 May; 31(5):915-25. PubMed ID: 20172007
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain.
Okamura N; Garau C; Duangdao DM; Clark SD; Jüngling K; Pape HC; Reinscheid RK
Neuropsychopharmacology; 2011 Mar; 36(4):744-52. PubMed ID: 21150909
[TBL] [Abstract][Full Text] [Related]
16. Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1.
Zhu H; Mingler MK; McBride ML; Murphy AJ; Valenzuela DM; Yancopoulos GD; Williams MT; Vorhees CV; Rothenberg ME
Psychoneuroendocrinology; 2010 Sep; 35(8):1119-32. PubMed ID: 20171785
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide S receptor: recent updates on nonpeptide antagonist discovery.
Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R; Cristalli G
ChemMedChem; 2011 Jul; 6(7):1163-71. PubMed ID: 21452188
[TBL] [Abstract][Full Text] [Related]
18. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.
Guerrini R; Salvadori S; Rizzi A; Regoli D; Calo' G
Med Res Rev; 2010 Sep; 30(5):751-77. PubMed ID: 19824051
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of human and murine neuropeptide s receptor variants.
Reinscheid RK; Xu YL; Okamura N; Zeng J; Chung S; Pai R; Wang Z; Civelli O
J Pharmacol Exp Ther; 2005 Dec; 315(3):1338-45. PubMed ID: 16144971
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide S Increases locomotion activity through corticotropin-releasing factor receptor 1 in substantia nigra of mice.
Li MS; Peng YL; Jiang JH; Xue HX; Wang P; Zhang PJ; Han RW; Chang M; Wang R
Peptides; 2015 Sep; 71():196-201. PubMed ID: 26239581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
